27th week of 2011 patent applcation highlights part 43 |
Patent application number | Title | Published |
20110166335 | Xenorhabdus sp. genome sequences and uses thereof - The present invention relates to nucleic acid sequences from | 2011-07-07 |
20110166336 | Identification of New Small RNAs and ORFs of E. Coli as Mediators of Cell and Intercell Regulation - The invention relates to new small RNAs and ORFs of | 2011-07-07 |
20110166337 | Maize Promoter P67 and Methods of Use - A promoter isolated from | 2011-07-07 |
20110166338 | REAGENT, CHAOTROPIC AGENT, AND REAGENT KIT FOR AND APPLICATIONS OF ISOLATING NUCLEIC ACID BY USE OF MAGNETIC CELLULOSE MATERIAL - Disclosed are a chaotropic agent; a reagent including a chaotropic agent and a lithium salt; a reagent kit including a chaotropic agent; a chaotropic agent, a reagent, a reagent kit, and a method for isolating a nucleic acid by use of a magnetic cellulose material; a method for binding a nucleic acid to a magnetic cellulose material; a method for isolating a nucleic acid; and a method for purifying a chromosome DNA. It is required that each of the chaotropic agents, the reagents, and the reagent kits works with at least one solid-phase, magnetic cellulose-containing carrier to isolate a nucleic acid from non-nucleic acid substances. In addition, each chaotropic agent includes an alcohol substance and a substrate solution for adjusting the alcohol substance to an appropriate concentration and thereby promoting binding of the nucleic acid in a sample to the magnetic cellulose. | 2011-07-07 |
20110166339 | CRYSTALLINE CARBOHYDRATE DERIVATIVE - α-Lactosamine hydrochloride, substantially free of β-lactosamine hydrochloride; a method of preparing α-lactosamine hydrochloride monohydrate from an anomeric mixture of lactosamine hydrochloride, including: preparing a solution including the anomeric mixture of lactosamine hydrochloride, water and at least one water-miscible organic solvent at a temperature of 0-100° C., and cooling the solution to cause crystallisation of α-lactosamine hydrochloride monohydrate; a method of preparing anhydrous α-lactosamine hydrochloride; and use of α-lactosamine hydrochloride as a food supplement or intermediate in synthesis. | 2011-07-07 |
20110166340 | Process for adjusting degree of acetyl substitution of cellulose acetate - A process for adjusting an intermolecular or intramolecular degree of acetyl substitution of cellulose acetate is disclosed. The process comprises ripening cellulose acetate in the presence of a catalyst, an acetyl donor, and water or an alcohol. The amount of water and the alcohol is in the range of 0.1 to 10 mol % based on the amount of the acetyl donor. | 2011-07-07 |
20110166341 | GLYOXAL FREE PURIFIED CATIONIC POLYGALACTOMANNAN - A glyoxal and boron free purified cationic polygalactomannan may be prepared by reacting a polygalactomannan flour, a nonionically derivatized polygalactomannan flour, or a mixture thereof, with a cationising reagent, adjusting the pH to be from about 4 to about 6; cross-linking the cationic with glyoxal, and filtering and water washing the cationic polygalactomannan to produce a glyoxalated purified cationic polygalactomannan containing not more than 70% by weight of water. In some cases it may be desirable to introduce a buffering agent to the glyoxalated purified cationic polygalactomannan to regulate the pH to from 8.0 to about 9.5, when measured at 1% (dry matter) in water. In other cases, it may be desirable to remove water to produce glyoxal free purified cationic polygalactomannan in powder form. Such compounds are particularly useful in personal care products. | 2011-07-07 |
20110166342 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF - A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: | 2011-07-07 |
20110166343 | THIENOPYRAZOLE DERIVATIVE HAVING PDE7 INHIBITORY ACTIVITY - To provide thienopyrazole derivatives inhibiting PDE 7 selectively, and therefore, enhance cellular cAMP level. Consequently, the compound is useful for treating various kinds of disease such as allergic diseases, inflammatory diseases or immunologic diseases. The compound is thienopyrazole compound represented by the following formula (I): | 2011-07-07 |
20110166344 | 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS - The invention is directed to 5,6-dihydro-1H-pyridin-2-one compounds of Formula I | 2011-07-07 |
20110166345 | THIAZOLYL-PYRAZOLOPYRIMIDINE COMPOUNDS AS SYNTHETIC INTERMEDIATES AND RELATED SYNTHETIC PROCESSES - The present invention relates to a synthetic intermediate of the formula: | 2011-07-07 |
20110166346 | NOVEL NAPTHALIMIDE-BENZIMIDAZOLE HYBRIDS AS POTENTIAL ANTITUMOR AGENTS AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides the compounds of general formula 5 and 9 useful as potential antitumour agents against human cancer cell lines. The present invention further provides the process for preparation of napthalimide-benzimidazole hybrids of general formula 5 and 9, n-1-2, R=n-methylpiperazine or morpholine (Formula 9), wherein: n=2-3, m=2-3 and R=n-methylpiperazine or morpholine. | 2011-07-07 |
20110166347 | PROCESS FOR PREPARATION OF MYCOPHENOLIC ACID, ITS SALT AND ESTER DERIVATIVES - The present invention discloses an isolation and purification process for mycophenolic acid obtained from the fermentation process. Invention further discloses preparation of sodium salt of mycophenolic acid and mycophenolate mofetil from mycophenolic acid. | 2011-07-07 |
20110166348 | NOVEL SALT OF MORPHOLINE DERIVATIVE - Provided are an acid addition salt of (+)-2-[(inden-7-yloxy)methyl]morpholine (compound A) and a novel crystal thereof, which are for use as a medicament or a drug substance, and which has high storage stability, particularly high stability against humidity and light. An acid addition salt of the compound A with an acid selected from benzenesulfonic acid and hydrobromic acid is a compound which is isolated in the form of a crystal, is a solid at room temperature, exhibits no hygroscopicity at such a level that causes a problem for use as a medicament or a drug substance, has stability against humidity and light, and is therefore extremely useful as a medicament or a drug substance. | 2011-07-07 |
20110166349 | GOLD CATALYZED HYDROAMINATION OF ALKYNES AND ALLENES - Methods are provided for the catalytic hydroamination of compounds having an alkyne or allene functional group, in which the compound is contacted with ammonia or an amine in the presence of a catalytic amount of a gold complex under conditions sufficient for hydroamination to occur. | 2011-07-07 |
20110166350 | NOVEL CRYSTAL FORMS OF 4-(2-AMINOPYRIDIN-4-YL)-3-(4-FLUOROPHENYL)-1-(1,4,5,6-TETRAHYDRO-6-OXOPYR- IDAZIN-3-YL)-1H-PYRAZOLE METHANESULFONATE AND METHODS FOR THEIR PREPARATION - The present inventions are directed to novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1H-pyrazole methanesulfonate, which is useful as a pharmaceutical product, and methods for their preparation. | 2011-07-07 |
20110166351 | METHOD FOR PREPARING 5-[2-(METHYLTHIO)ETHOXY]PYRIMIDINE-2-AMINE - A novel method for preparing 5-[2-(methylthio)ethoxy]pyrimidin-2-amine useful as a regent or raw material for manufacture of medicaments, agricultural chemicals, and industrial products, which comprises alkanoylating the amino group of a 2-amino-4-alkoxypyrimidine, then converting the resultant into a 4-hydroxypyrimidine compound by a treatment with anhydrous aluminum chloride, further etherifying the 4-hydroxypyrimidine compound by a reaction with a 2-haloethyl methyl sulfide in the presence of a base, and removing the alkanoyl group to obtain 5-[2-(methylthio)ethoxy]pyrimidin-2-amine. | 2011-07-07 |
20110166352 | PROCESS FOR MAKING STERILE ARIPIPRAZOLE OF DESIRED MEAN PARTICLE SIZE - A process is provided for making sterile aripiprazole having an average particle size less than 100 microns but preferably greater than 25 microns employing an impinging jet crystallization procedure. The resulting bulk aripiprazole of desired particle size may be used to form a sterile freeze-dried aripiprazole formulation, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. | 2011-07-07 |
20110166353 | Cyclopamine Analogues and Methods of Use Thereof - The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers. | 2011-07-07 |
20110166354 | METHOD FOR PRODUCING OPTICALLY ACTIVE AMINO ACID DERIVATIVE - The present application relates to a method for producing an optically active α-amino acid derivative, comprising steps of reacting an α-haloester derivative represented by the general formula (1): | 2011-07-07 |
20110166356 | METHOD FOR PREPARING MONTELUKAST SODIUM SALTS - Disclosed is a method for preparing a montelukast sodium salt of Formula 1. The method includes coupling a methanesulfonyl compound of Formula 2 below with a compound of Formula 3 below in the presence of a bistrimethylsilylamide alkali metal salt, further adding an alkali metal base thereto and hydrolyzing the mixture by heating to prepare a compound of Formula 4 below, reacting the compound of Formula 4 with 4-tert-butylcyclohexylamine, followed by purification, to prepare an amine salt of Formula 5, and converting the amine salt of Formula 5 into a sodium salt. | 2011-07-07 |
20110166357 | METHOD FOR PRODUCING N-SUBSTITUTED-TRANS-4-AZIDOPIPERIDINE-3-OL - An N-substituted-trans-4-azidopiperidin-3-ol represented by formula (II-1) | 2011-07-07 |
20110166358 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT - The present invention offers compounds or their salts expressed by formula (I) (in the formula, X indicates an alkyl group, or the like; Y indicates an alkyl group; Z indicates a respectively independent nitro group, or the like; n indicates any integer from 0 to 3; A indicates carbon atom, or the like, and hydrogen atom is bonded thereto in the case where the carbon atom is not substituted with Z; D indicates oxygen atom, or the like; W indicates hydrogen atom, or the like; R | 2011-07-07 |
20110166359 | PROCESS FOR PREPARING OXAZOLINE-PROTECTED AMINODIOL COMPOUNDS USEFUL AS INTERMEDIATES TO FLORFENICOL - Processes for preparing oxazoline compounds are disclosed. These oxazoline compounds are useful intermediates in the preparation of Florfenicol and related compounds. | 2011-07-07 |
20110166360 | Catalytic Process for Asymmetric Hydrogenation - A process for preparing the S or R enantiomer of a compound of formula A, | 2011-07-07 |
20110166361 | CRYSTALLINE FORMS OF [3-(4- -PHENOXY)-PROPYL]-DIETHYL-AMINE - The present invention relates to crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethylamine (“COMPOUND I”) useful in the treatment of RAGE mediated diseases. | 2011-07-07 |
20110166362 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL - Discloses is a compound represented by the formula (1): | 2011-07-07 |
20110166363 | PROCESS FOR THE PREPARATION OF ASENAPINE AND INTERMEDIATE PRODUCTS USED IN SAID PROCESS - The invention relates to a novel process for the preparation of asenapine, i.e. trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, as well as to novel intermediate products for use in said process. | 2011-07-07 |
20110166364 | SYNTHESIS OF 3--5-[2-(PHENYLSULFONYL)ETHYL]-1H-INDOLE - The present invention refers to the synthesis of 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole, a drug known by the name Eletriptan, or of its salts. In particular, the present invention regards a process for the synthesis of Eletriptan or of its salt, comprising the following steps: a) Salifying the intermediate of Formula (6), using a dicarboxylic acid to obtain a derived salt; b) Optionally, purifying said raw salt obtained according to step a) by solvent crystallization to obtain a purified salt of the intermediate of Formula (6); c) Converting said salt of the intermediate of formula (6) according to step a) or said purified salt according to step b) into an intermediate of formula (10); d) Converting the intermediate of Formula (10) into Eletriptan or its salt. | 2011-07-07 |
20110166365 | Collagen peptide, dipeptide and malady inhibitor - A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component. | 2011-07-07 |
20110166366 | Novel Chalcogenoxanthylium Dyes for Purging Blood Pathogens and for Photodynamic Therapy - Provided are chalcogenoxanthylium compounds which can effectively be used as sensitizers in photodynamic therapy, virucides in photodynamic antimicrobial chemotherapy and reversal agents of Pgp function in cancer cells. Further provided is a general method for the preparation of chalcogenoxanthylium compounds. | 2011-07-07 |
20110166367 | REACTOR TEMPERATURE CONTROL USING PROBABILITY DISTRIBUTION - Embodiments of the present invention generally relate to temperature control of a reactor using probability distribution of temperature measurements. In one embodiment, a method of controlling a temperature of a chemical reaction includes injecting a reactant stream into a reactor and through a catalyst bed of the reactor. The reactant stream includes a hydrocarbon and oxygen. Injection of the reactant stream into the catalyst bed causes an exothermic chemical reaction. The method further includes circulating a coolant through the reactor, thereby removing heat from the catalyst bed. The method further includes measuring temperature at a plurality of locations in the catalyst bed. The method further includes calculating a fraction of the catalyst bed greater than a predetermined maximum temperature limit using a probability distribution generated using the temperature measurements. | 2011-07-07 |
20110166368 | METHOD AND SYSTEM FOR OBTAINING SOLID REACTION PRODUCTS FROM SOLUTIONS - A process for recovering solid reaction products during partial oxidation of hydrocarbons in a liquid solvent as a reaction medium by multi-stage evaporative crystallization includes determining a final temperature of the multi-stage evaporative crystallization based on a melting point of the solvent. The pressure and temperature of the solvent is reduced in steps via successive crystallization stages until the final temperature is reached. Each of the crystallization stages includes a compressor configured to perform the reducing of the pressure and to withdraw vapors formed. The vapors from the compressor of a lower expansion pressure crystallization stage are introduced into a vapor discharge conduit of a next successive higher expansion pressure crystallization stage upstream of the compressor of the higher expansion pressure crystallization stage. | 2011-07-07 |
20110166369 | Process for purifying hydrogen chloride - Process for purifying hydrogen chloride, comprising at least one step of bringing said hydrogen chloride into contact with a scrubbing agent containing at least one chlorohydrin. | 2011-07-07 |
20110166370 | Scattered Branched-Chain Fatty Acids And Biological Production Thereof - Methods and cells for producing scattered branched-chain fatty acids are provided. For example, the invention provides a method for producing branched-chain fatty acid comprising a methyl on one or more even number carbons. The method comprises culturing a cell comprising an exogenous or overexpressed polynucleotide comprising a nucleic acid sequence encoding a polypeptide that catalyzes the conversion of propionyl-CoA to methylmalonyl-CoA and/or an exogenous or overexpressed polynucleotide comprising a nucleic acid sequence encoding a polypeptide that catalyzes the conversion of succinyl-CoA to methylmalonyl-CoA, under conditions allowing expression of the polynucleotide(s) and production of branched-chain fatty acid. The cell produces more branched-chain fatty acid comprising a methyl on one or more even number carbons than an otherwise similar cell that does not comprise the polynucleotide(s). A cell that produces branched-chain fatty acid and the branched-chain fatty acid also are provided. | 2011-07-07 |
20110166371 | GENETICALLY MODIFIED PLANT CAPABLE OF BIOSYNTHESIZING CAPSINOID - The present invention provides a genetically modified plant that biosynthesizes an increased amount of capsinoids, a method of producing the genetically modified plant, and a production method of capsinoids from the genetically modified plant. More particularly, the present invention provides a genetically modified plant capable of producing capsinoids, which shows a decreased expression or activity of an enzyme that catalyzes an amino group conversion reaction from vanillin to vanillylamine as compared to wild strains, and the like. As a method of suppressing expression or activity of an enzyme, an introduction of DNA encoding an antisense RNA, iRNA, ribozyme or dominant-negative mutant for the target gene, a destruction of the gene by a knockout method, mutagen treatment or transposon insertion, an introduction of a gene encoding an antibody against the enzyme and the like can be mentioned. | 2011-07-07 |
20110166372 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANE CARBOXYLIC ACID ESTER COMPOUND, ASYMMETRIC COPPER COMPLEX, AND OPTICALLY ACTIVE SALICYLIDENEAMINOALCOHOL COMPOUND - A process for producing an optically active cyclopropanecarboxylic acid ester compound represented by the formula (4): | 2011-07-07 |
20110166373 | METHOD FOR PRODUCING AMINO-ORGANOSILANES - In the preparation of aminoorganylsilanes and cyclic aminosilanes by reaction of an organyl amine with a haloorganylsilane, the byproduct halide salt of the amine reactant is decomposed to amine by addition of a base whose halide salt forms a liquid phase at a temperature below 200° C., and the liquid base halide is separated from the reaction mixture. | 2011-07-07 |
20110166374 | METHOD FOR PRODUCING ANIONIC SURFACTANT - Disclosed is the method for producing an anionic surfactant powder, including removing impurities by introducing gas into a crude anionic surfactant containing water in a content of 0.01 to 5% by weight in a granulator or drier, having an agitating blade. Also disclosed is the method for producing an anionic surfactant powder, including introducing a gas along with the surface of an inner wall of a granulator or drier having an agitating blade at a reduced pressure to produce the anionic surfactant powder. | 2011-07-07 |
20110166375 | FLUORINE-CONTAINING BORONIC ACID ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME - A fluorine-containing boronic acid ester represented by the general formula: | 2011-07-07 |
20110166376 | PREPARATION OF NITRILES FROM ETHYLENICALLY UNSATURATED COMPOUNDS - A process for the hydrocyanation of a hydrocarbon-based compound having at least one site of ethylenic unsaturation into a nitrile compound includes reaction thereof, in a liquid medium, with hydrogen cyanide in the presence of a catalyst containing a metal element selected from among the transition metals and an organophosphorus ligand, wherein the organophosphorus ligand is a mixture of at least one monodentate organophosphite compound and at least one monodentate organophosphine compound; the subject process is especially useful for the synthesis of adiponitrile from butadiene. | 2011-07-07 |
20110166377 | METHOD FOR THE SEPARATION OF PENTENENITRILE ISOMERS - A process is described for separating mixtures of isomeric pentenenitriles, in which at least one isomer is removed from the mixture, wherein the separation of the substance mixtures of isomeric pentenenitriles is effected distillatively under reduced pressure. | 2011-07-07 |
20110166378 | METHOD AND APPARATUS FOR REFINING BIODIESEL - Method and apparatus for producing biodiesel fuel, i.e., alkyl ester, from vegetable and/or animal oil. A transesterification catalyst is prepared in a base catalyst tank by spraying alkyl alcohol under pressure through jets at metal hydroxide pellets until the pellets have fully reacted with the alcohol. The oil is heated and transesterified in the presence of alkyl alcohol and the transesterification catalyst in a closed, recirculating transesterification flow system under slight cavitation to yield product alkyl ester and product glycerol. Cavitation is achieved by permitting air to enter the transesterification flow system through an adjustable air inlet valve. When permitted to stand, product alkyl ester forms an upper layer that is decanted and subjected to purification steps, to remove particulates and alkyl alcohol from the product alkyl ester, and a lower layer of product glycerol is drained away. Purification of the product alkyl ester preferably includes subjecting the product alkyl ester to an overhead water mist in a wash tank with simultaneous infusion of a stream of air bubbles. Alcohol vapor is reclaimed as liquid alcohol within an alcohol condenser and stored for reuse. If the oil contains free fatty acids, prior to transesterification, the oil is heated and the free fatty acids are esterified in the presence of an esterification catalyst and alkyl alcohol. For safety, baffles and explosion damper/flame arrestors are provided in locations where flammable vapors pose a risk. | 2011-07-07 |
20110166379 | Method of synthesis and purification of N-6-Trimethyl-L-Lysine and derivative compounds - The invention provides a method of synthesis of N-6-trimethyl-L-lysine (TML) derivative compounds for potential treatment of disorders resulting from deficiencies in the TML-carnitine pathway. The invention also provides a method of purification of TML and TML derivative compounds. The treatment of conditions of the diseases late infantile neuronal ceroid lipofuscinosis (LINCL) and neuronal ceroid lipofuscinosis (NCL) with TML were shown in the original parent application. | 2011-07-07 |
20110166380 | Derivative compounds of N-6-Trimethy-L-Lysine for therapeutic use - The invention provides derivative compounds of N-6-trimethyl-L-lysine (TML) for potential treatment of disorders resulting from deficiencies in the TML-carnitine pathway. The invention also provides a method of purification of TML and TML derivative compounds. The treatment of conditions of the diseases late infantile neuronal ceroid lipofuscinosis (LINCL) and neuronal ceroid lipofuscinosis (NCL) with TML were shown in the original parent application. | 2011-07-07 |
20110166381 | LIGHT FILTERS COMPRISING A NATURALLY OCCURRING CHROMOPHORE AND DERIVATIVES THEREOF - A composition comprising a polymer backbone and at least one side group, wherein the side group comprises a benzene ring-based chromophore comprising a ketone at the 1-position, a substituted or unsubstituted amino group at the 2-position, and an oxygen atom at the 3-position of the benzene ring. The chromophore is a kynurenine-based compound. Methods of making and using the composition are also provided. The composition can be used in an ophthalmic lens or device for protecting the retina by blocking UV rays and filtering violet rays. | 2011-07-07 |
20110166382 | PROCESSES FOR OBTAINING A PHOSPHONIC ACID FROM A PHOSPHONIC ACID ANHYDRIDE - The present invention relates to a process for recovering a phosphonic acid. The present invention also relates to the conversion of a phosphonic acid to a phosphonic acid anhydride. | 2011-07-07 |
20110166383 | PROCESS FOR THE PRODUCTION OF GLYCOLIC ACID - A process for producing glycolic acid from carbon monoxide and formaldehyde using a catalyst comprising an acidic polyoxometalate compound encapsulated within the pores of a zeolite, wherein the zeolite has cages larger than the acidic polyoxometalate compound, the zeolite also having pores with a diameter smaller than that of the acidic polyoxometalate compound. | 2011-07-07 |
20110166384 | CATALYST FOR PRODUCING ACRYLIC ACID AND PROCESS FOR PRODUCING ACRYLIC ACID USING THE CATALYST - A catalyst for producing acrylic acid from propane and/or acrolein by gas-phase catalytic oxidation with molecular oxygen-containing gas, comprising a catalytic active component containing molybdenum and vanadium as essential elements, and having a crystallinity T of 5% or more and 20% or less in the 20 range of 5° to 90°, measured by an X-ray diffraction analysis with Cu-Kα radiation; and a process for producing acrylic acid by gas-phase catalytic oxidation of propane and/or acrolein with molecular oxygen, comprising the step of conducting the gas-phase catalytic oxidation in the presence of the catalyst. According to the catalyst and the process for producing acrylic acid of the present invention, it is possible to stably produce acrylic acid at a high yield for a long period. | 2011-07-07 |
20110166385 | METHOD FOR SEPARATING A CARBOXYLIC ACID IN SALIFIED FORM BEARING AT LEAST ONE HALOGEN ATOM - The subject of the present invention is a method for separating a carboxylic acid in salified form bearing at least one halogen atom at the α position of the carbonyl group from a medium comprising it. The method according to the invention, for separating a carboxylic acid in salified form bearing at least one halogen atom at the α position of the carbonyl group from an aqueous medium comprising it, is characterized by the fact that the latter is brought into contact with an onium salt leading to the formation of two phases: an organic phase comprising the salt resulting from the reaction of the salt of the carboxylic acid bearing at least one halogen atom at the α position of the carbonyl group and of the onium salt leading to the displacement of the cation from the carboxylic acid by the onium, an aqueous phase comprising the various salts, in particular the one resulting from the reaction of the cation of the carboxylic acid with the anion of the onium, and by the fact that the organic and aqueous phases are then separated and that the onium salt of the carboxylic acid is recovered from the organic phase. | 2011-07-07 |
20110166386 | Method Of Dehydrating Acetic Acid - The invention pertains to a process for dehydrating wet acetic acid. One embodiment of the invention comprises contacting wet acetic acid with acetyl chloride. Another embodiment of the invention comprises contacting wet acetic acid; acetic anhydride; and a catalytic effective amount of hydrogen chloride, acetyl chloride, or a chlorosilane. | 2011-07-07 |
20110166387 | High-Purity N-Ethylmethylamine and Process for Preparing Same - The present invention relates to N-ethylmethylamine having a very high degree of purity, that is to say very low contents of impurities commonly encountered in conventional industrial processes, and also to the process for preparing, on an industrial scale, high-purity N-ethylmethylamine. | 2011-07-07 |
20110166388 | PROCESS FOR PREPARING 2,2-DIFLUOROETHYLAMINE AND SALTS THEREOF PROCEEDING FROM DIFLUOROACETONITRILE - The present invention relates to a process for preparing 2,2-difluoroethylamine of the formula (I) and salts thereof, for example sulphates, hydrochlorides or acetates, which proceeds from difluoroacetonitrile. | 2011-07-07 |
20110166389 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same - The invention relates to novel phosphonium borate compounds represented by the Formula: (R | 2011-07-07 |
20110166390 | CARBON NANOHOOPS AND METHODS OF MAKING - The present invention provides cycloparaphenylene compounds, their macrocyclic precursors, and methods for making the compounds. The cycloparaphenylene compounds can be used to prepare armchair carbon nanotubes. | 2011-07-07 |
20110166391 | DIALDEHYDE COMPOUND, PREPARATION METHOD THEREOF, AND SYNTHETIC METHOD OF CAROTENOIDS USING THE SAME - The novel C dialdehyde compound which can be efficiently utilized in the synthesis of carotenoid compounds based on the sulfone chemistry, the preparation method of the same, and the expeditious and practical synthetic processes for lycopene and β-carotene by the use of the above novel compound are disclosed. The syntheses of lycopene and β-carotene are characterized by the processes of the coupling reaction between two equivalents of geranyl sulfone or cyclic geranyl sulfone and the above C dialdehyde, the functional group transformation reactions of the diol in the resulting C 40 coupling products to X's (either halogens or ethers), and the double elimination reactions of the functional groups of the benzenesulfonyl and X to produce the fully conjugated polyene chain of the carotenoids. | 2011-07-07 |
20110166392 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds - Novel processes for preparing poly(pentafluorosulfanyl)aromatic compounds are disclosed. Processes include reacting an aryl sulfur compound with a halogen and a fluoro salt to form a poly(halotetrafluorosulfanyl)aromatic compound. The poly(halotetrafluorosulfanyl)aromatic compound is reacted with a fluoride source to form a target poly(pentafluorosulfanyl)aromatic compound. | 2011-07-07 |
20110166393 | METHOD FOR PREPARING CATALYST - The present invention provides a method of preparing the copper-containing hydrogenation catalyst having high activity by liquid phase reduction without decreasing purity of the solvent and a method for efficiently producing an alcohol. The present invention provides the method of preparing the copper-containing hydrogenation catalyst, including reducing a molded precursor of the copper-containing hydrogenation catalyst by supplying hydrogen gas or a mixture of hydrogen gas with an inert gas at a temperature of 50 to 150° C. in the presence of a solvent to obtain the copper-containing hydrogenation catalyst, wherein the reduction is conducted at an average reduction velocity of the copper-containing hydrogenation catalyst of not more than 3.0% by weight/hour. The present invention also provides the method of producing an alcohol, including preparing the copper-containing hydrogenation catalyst by the method of preparation, and subjecting a carboxylic acid or a carboxylic acid ester to catalytic reduction with hydrogen in the presence of the prepared copper-containing hydrogenation catalyst. | 2011-07-07 |
20110166394 | METHOD FOR CONTROLLING SIZE OF SPHERICAL CARRIER FOR OLEFIN POLYMERIZATION CATALYST - Provided is a method for controlling the size of a dialkoxy magnesium carrier used in preparation of an olefin polymerization catalyst. Specifically, provided is a method for controlling the size of a dialkoxy magnesium carrier for preparation of an olefin polymerization catalyst which includes preparation of a dialkoxy magnesium carrier by reacting metal magnesium with an alcohol in the presence of an reaction initiator such as magnesium halide or nitrogen halide, by adding the metal magnesium and the alcohol to the reaction in divided portion(s) of 1-3. | 2011-07-07 |
20110166395 | METHOD FOR THE PRODUCTION OF NANOCRYSTALLINE NICKEL OXIDES - The present invention relates to a method for the production of nanocrystalline nickel oxides as well as the nickel oxides produced by the method according to the invention and the use thereof as catalyst following reduction to nickel metal, in particular for hydrogenation reactions. | 2011-07-07 |
20110166396 | HYDROCONVERSION PROCESS AND CATALYST - The invention relates to a process and hydrodeoxygenation catalyst for producing high-quality diesel and naphtha fuels from a feedstock that contains oxygen containing components derived from renewable organic material in which the hydrodeoxygenation catalyst is a supported Mo catalyst and in which the support has a bimodal porous structure. | 2011-07-07 |
20110166397 | METHOD FOR CATALYTICALLY CRACKING WASTE PLASTICS AND APPARATUS FOR CATALYTICALLY CRACKING WASTE PLASTICS - To provide a method for catalytically cracking waste plastics wherein the efficiency in decomposition is high; even polyethylene composed of linear chain molecules difficult in decomposition is decomposable at a low temperature and decomposed residue is hardly produced; the process is simple since dechlorination can be achieved at the same time with catalytically cracking waste plastics in one reaction vessel; and oil fractions can be recovered at 50% or more on a net yield basis. The method for catalytically cracking waste plastics of the present invention has a constitution in which waste plastics are loaded as a raw material into a granular FCC catalyst heated to a temperature range from 350° C. to 500° C. inside a reaction vessel, thereby decomposing and gasifying the waste plastics in contact with the FCC catalyst. | 2011-07-07 |
20110166398 | PROCESS FOR PREPARING A Ni/Sn SUPPORTED CATALYST FOR THE SELECTIVE HYDROGENATION OF POLYUNSATURATED HYDROCARBONS - A process is described for preparing a catalyst comprising at least one porous support and at least one metallic phase containing nickel and tin in a proportion such that the Sn/Ni molar ratio is in the range 0.01 to 0.2, said process comprising at least the following steps in succession:
| 2011-07-07 |
20110166399 | METHOD FOR IMPROVING PRODUCTIVITY AND PROCESS STABILITY IN STYRENE MANUFACTURING SYSTEM HAVING MULTIPLE REACTORS CONNECTED IN SERIES - Provided is a method for improving productivity and process stability in styrene monomer manufacturing system which uses ethylbenzene dehydrogenation and multiple reactors connected in series by divergence of the feed containing steam and ethylbenzene and injection thereof into a certain point of the system. | 2011-07-07 |
20110166400 | DIADEHYDE COMPOUND, PREPARATION METHOD THEREOF, AND SYNTHETIC METHOD OF CAROTENOIDS USING THE SAME - The novel C dialdehyde compound which can be efficiently utilized in the synthesis of carotenoid compounds based on the sulfone chemistry, the preparation method of the same, and the expeditious and practical synthetic processes for lycopene and β-carotene by the use of the above novel compound are disclosed. The syntheses of lycopene and β-carotene are characterized by the processes of the coupling reaction between two equivalents of geranyl sulfone or cyclic geranyl sulfone and the above C dialdehyde, the functional group transformation reactions of the diol in the resulting C 40 coupling products to X's (either halogens or ethers), and the double elimination reactions of the functional groups of the benzenesulfonyl and X to produce the fully conjugated polyene chain of the carotenoids. | 2011-07-07 |
20110166401 | Novel Molecular Sieve Composition EMM-12, A Method of Making and a Process of Using the Same - This disclosure relates to an EMM-12 molecular sieve having, in its as-synthesized form and in calcined form, an X-ray diffraction pattern including peaks having a d-spacing maximum in the range of 14.17 to 12.57 Angstroms, a d-spacing maximum in the range of 12.1 to 12.56 Angstroms, and non-discrete scattering between about 8.85 to 11.05 Angstroms or exhibit a valley in between the peaks having a d-spacing maximum in the range of 10.14 to 12.0 Angstroms and a d-spacing maximum in the range from 8.66 to 10.13 Angstroms with measured intensity corrected for background at the lowest point being not less than 50% of the point at the same XRD d-spacing on the line connecting maxima in the range of 10.14 to 12.0 Angstroms and in the range from 8.66 to 10.13 Angstroms | 2011-07-07 |
20110166402 | Novel Molecular Sieve Composition EMM-13, A Method of Making and a Process of Using the Same - This disclosure relates to a molecular sieve comprising a framework of tetrahedral atoms bridged by oxygen atoms, the tetrahedral atom framework being defined by a unit cell with atomic coordinates in nanometers shown in Table 3. | 2011-07-07 |
20110166403 | Alkylaromatic Production Process - The present disclosure provides a process for selectively producing a desired monoalkylated aromatic compound comprising the step of contacting in a reaction zone an alkylatable aromatic compound with an alkylating agent in the presence of catalyst comprising a porous crystalline material under at least partial liquid phase conditions, said catalyst manufactured from extrudate to comprise catalytic particulate material of from about 125 microns to about 790 microns in size, having an Effectiveness Factor increased from about 25% to about 750% from that of the original extrudate, and having an external surface area to volume ratio of greater than about 79 cm | 2011-07-07 |
20110166404 | DIALDEHYDE COMPOUND, PREPARATION METHOD THEREOF, AND SYNTHETIC METHOD OF CAROTENOIDS USING THE SAME - The novel C dialdehyde compound which can be efficiently utilized in the synthesis of carotenoid compounds based on the sulfone chemistry, the preparation method of the same, and the expeditious and practical synthetic processes for lycopene and β-carotene by the use of the above novel compound are disclosed. The syntheses of lycopene and β-carotene are characterized by the processes of the coupling reaction between two equivalents of geranyl sulfone or cyclic geranyl sulfone and the above C dialdehyde, the functional group transformation reactions of the diol in the resulting C 40 coupling products to X's (either halogens or ethers), and the double elimination reactions of the functional groups of the benzenesulfonyl and X to produce the fully conjugated polyene chain of the carotenoids. | 2011-07-07 |
20110166405 | PROCESS FOR PRODUCING PARAFFINIC HYDROCARBONS - A process for producing paraffinic hydrocarbons from a feedstock comprising triglycerides, diglycerides, monoglycerides and/or fatty acids, the process comprising the following steps: (a) hydrode oxygenating the triglycerides, diglycerides, monoglycerides and/or fatty acids in the feedstock by contacting hydrogen and the feedstock with a hydrogenation catalyst at a temperature in the range of from 250 to 380° C. and a total pressure in the range of from 20 to 160 bar (absolute), to obtain an effluent comprising paraffinic hydrocarbons and water; (b) separating a liquid stream rich in paraffinic hydrocarbons from the effluent obtained in step (a); and (c) hydroisomerising the paraffinic hydrocarbons in the liquid stream rich in paraffinic hydrocarbons by contacting hydrogen and the liquid stream with a hydroprocessing catalyst comprising sulphided Ni and sulphided W or Mo as hydrogenation components on a carrier comprising amorphous silica-alumina and/or a zeolitic compound at a temperature in the range of from 280 to 450° C. and a total pressure in the range of from 20 to 160 bar (absolute). | 2011-07-07 |
20110166406 | Improved Device for Simulated Moving Bed Separation - A device (SMB) for separation by simulated moving bed adsorption comprises a plurality of elementary zones Z | 2011-07-07 |
20110166407 | Heart Treatment Kit, System, and Method For Radiosurgically Alleviating Arrhythmia - Radiosurgical treatments of tissues of the heart mitigate arrhythmias and treat other tumerous and non-tumerous disease using an implanted fiducial positioned in or near the heart using cardiac catheterization techniques. The fiducials may be implanted after diagnostic and planning images of the target tissues have been acquired. Fiducial implantation may take place the day of a scheduled radiosurgical treatment. Techniques to accommodate post-planning fiducial implantation may include registration of the implanted fiducial location with the treatment plan, and active fiducials may limit collateral imaging radiation exposure while enhancing tracking accuracy. | 2011-07-07 |
20110166408 | HEART TISSUE SURFACE CONTOUR-BASED RADIOSURGICAL TREATMENT PLANNING - A system that generates a three-dimensional model of a tissue surface, for example the inner surface of the heart from two-dimensional image data slices. On this surface, one or more pattern lines are drawn, e.g., by a physician using a user interface, to designate desired lesion(s) on the surface. From the pattern lines, a three-dimensional volume for a lesion can be determined using known constraints. Advantageously, the series of boundaries generated by the three-dimensional volume may be projected back onto the individual CT scans, which then may be transferred to a standard radiosurgical planning tool. A dose cloud may also be projected on the model to aid in evaluating a plan. | 2011-07-07 |
20110166409 | EGFR AND PTEN GENE ALTERATIONS PREDICTS SURVIVAL IN PATIENTS WITH BRAIN TUMORS - The invention relates to methods of predicting the clinical outcome of brain cancer patients based on the LOH levels of the PTEN gene and on the expression levels or the polysomy/amplification levels of EGFR gene in a sample from said patients. | 2011-07-07 |
20110166410 | METHOD AND SYSTEM FOR BRACHYTHERAPY - A brachytherapy system for a target region ( | 2011-07-07 |
20110166411 | WARMING THERAPY DEVICE INCLUDING RESUSCITATION CONTROL SYSTEM - An apparatus and method for performing warming therapy is described. In one exemplary embodiment, the apparatus includes a patient support assembly ( | 2011-07-07 |
20110166412 | SELF-ADJUSTING ATTACHMENT STRUCTURE FOR A CARDIAC SUPPORT DEVICE - A cardiac support device including a jacket and elastic attachment structure for self-securing the jacket to a heart. The attachment structures can include undulating metal and polymer elements, a silicone band and elastomeric filaments on a base end of the jacket. | 2011-07-07 |
20110166413 | COMPLIANT CARDIAC SUPPORT DEVICE - A jacket of biological compatible material has an internal volume dimensioned for an apex of the heart to be inserted into the volume and for the jacket to be slipped over the heart. The jacket has a longitudinal dimension between upper and lower ends sufficient for the jacket to surround a lower portion of the heart with the jacket surrounding a valvular annulus of the heart and further surrounding the lower portion to cover at least the ventricular lower extremities of the heart. The jacket is adapted to be secured to the heart with the jacket surrounding at least the valvular annulus and the ventricular lower extremities. The jacket is adjustable on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain circumferential expansion of the heart beyond the maximum adjusted volume during diastole and to permit unimpeded contraction of the heart during systole. | 2011-07-07 |
20110166416 | CAPSULE MEDICAL APPARATUS - A capsule medical apparatus to be introduced into a subject includes a tissue collecting unit that collects in-vivo tissue; a storage unit that stores therein the in-vivo tissue that is collected by the tissue collecting unit; a liquid storing unit that stores therein liquid for suppressing autolysis of in-vivo tissue; a liquid supplying unit that supplies the liquid in the liquid storing unit to the storage unit; and a control unit that allows, in response to an instruction to start collecting the in-vivo tissue, the tissue collecting unit to collect desired in-vivo tissue and to store the collected in-vivo tissue in the storage unit and that then allows the liquid supplying unit to supply the liquid to the storage unit and makes the storage unit be in a liquid-tight state. | 2011-07-07 |
20110166417 | METHOD AND DEVICE FOR REPAIR OF DEGENERATIVE CARTILAGE - The present invention relates, in general to methods for treating degenerative cartilage in an individual comprising administering a composition that increases bone morphogenic protein (BMP) expression directly into injured or damaged cartilage, such as in a vertebral disc or a joint, wherein the composition is in a controlled release formulation. | 2011-07-07 |
20110166418 | MEDICAL IMAGE PROCESSING SYSTEM AND A METHOD FOR PROCESSING A MEDICAL IMAGE - The medical image processing device comprises a detection part, a storage part, an image generation part, and a display-control part. The detection part detects positions and directions of an endoscope. The storage part stores medical image data showing tubular tissues generated by a medical imaging device different from the endoscope. The image generation part generates virtual endoscopic image data showing the internal portion of the tubular tissues based on the medical image data having a position that is a predetermined distance away from the position of the endoscope as a viewpoint. The display-control part receives endoscopic image data showing the internal portion of the tubular tissues generated by the endoscope and displays an endoscopic image based on the endoscopic image data and a virtual endoscopic image based on the virtual endoscopic image data on a display part. | 2011-07-07 |
20110166419 | ENDOSCOPE HAVING A SHAFT TUBE AND OPTIC - A surgical endoscope having a shaft tube that can be connected at its proximal end area to a flushing water inlet and in the distal end area, has at least one lateral opening and having an optic extending through the shaft tube, said optic being designed with a smaller cross-section than the internal cross-section of the shaft tube, and through said optic an image guide extends along the length thereof, where a suction tube is arranged in the free internal cross-section of the shaft tube next to the optic, the suction opening of said suction tube being arranged distally in front of the shaft tube, said suction tube also being proximally connected to a suction device, and where in the distal end region of the shaft tube a locking element, locking the remaining free internal cross-section, thereof is disposed. | 2011-07-07 |
20110166420 | IMAGING METHOD AND APPARATUS - An imaging apparatus and method are provided. The probe for an imaging apparatus includes a manually manipulable proximal portion; a straight distal portion with a distal tip for locating at a site to define an observational field; and a curved portion between the proximal portion and the distal portion. The imaging method includes the steps of locating a distal tip of an imaging probe at a site to define an observational field; irradiating the observational field from the distal tip; and collecting a return signal at the distal tip; wherein the probe comprises a manually manipulable proximal portion. The apparatus and method provided herein are useful for various applications including but not limited to endomicroscopy and other microsurgical procedures performed under optical stereoscopic magnified visualization, such as neurosurgery, ENT/facial surgery and spinal surgery. | 2011-07-07 |
20110166421 | Enhanced Otoscope Cover - Some embodiments provide an attachment for adapting an examination tool to identify a foreign object within a small orifice and to safely extract the foreign object using the examination tool. In some embodiments, the attachment is an enhanced otoscope cover for adapting an otoscope to simultaneously examine the ear canal and remove accumulated cerumen from the ear canal. The attachment includes a cover to couple the attachment to the otoscope and to provide a focal view point for the attachment. The attachment includes a support that extends from the cover. An extraction tip is located at the end of the support and is used to engage and extract cerumen and other objects. | 2011-07-07 |
20110166422 | RIGIDIZABLE ENDOLUMINAL ACCESS DEVICE - A rigidizable endoluminal access device includes a handle assembly | 2011-07-07 |
20110166423 | FOAM PORT INTRODUCTION SYSTEM INCLUDING DILATOR - A surgical apparatus for positioning within a tissue tract accessing an underlying body cavity, comprising a compressible seal anchor member including a leading end configured for insertion within the tissue tract and a trailing end configured to remain outside of the tissue tract, the compressible seal anchor member having at least one longitudinal port extending between the leading and trailing ends for substantially sealed reception of an object therein, the compressible seal anchor member including a bore for receipt of a dilator. | 2011-07-07 |
20110166424 | SPLIT HOOP WOUND RETRACTOR WITH GEL PAD - An incrementally adjustable wound retractor, which provides access to a body cavity, includes an inner ring having a diameter greater than the desired diameter of the wound incision, an outer ring having an annular axis and a diameter greater than the desired diameter of the wound incision, and a flexible sleeve disposed in a generally cylindrical form between the inner and outer rings. The outer ring includes first and second circular tubes spaced apart axially with each including a lumen having a rigid, noncompliant split hoop placed therein. The outer ring may be rolled over itself and around the annular axis to retract the sleeve with sufficient force to stretch the incision to the desired diameter. A gel cap seal may be coupled to the outer ring outside of the biological body to seal the opening produced by the wound retractor between the body cavity and outside the body cavity. | 2011-07-07 |
20110166425 | Flexible Disposable Surgical Port - A surgical apparatus for introduction of laparoscopic instruments into an anatomical cavity through tissue at an entry site. The apparatus includes a body with a frustoconical-shaped wall. The body defines an interior cavity, an open bottom, and a substantially closed top wall with openings from which a plurality of ports extend upward therefrom. The ports are adapted to receive the laparoscopic instruments for introduction through the interior cavity and open bottom of the body into the anatomical cavity. In the preferred embodiment, the frustoconical-shaped wall of the body is placed through an incision in the umbilicus. In one aspect of the invention, the body is a unitary one-piece molded structure. A reinforcing belt or plate formed from a relatively hard material can be integral to the body, and separately formed port caps each having a septum may be bonded to the ports. | 2011-07-07 |
20110166426 | MODULE FOR A COMPUTER INTERFACE - The present invention provides a module for a computer interface including a transducer wherein the transducer receives a measurement value and makes this measurement value available for monitoring an individual's health by means of the computer interface, for example, for monitoring an individual's blood glucose level, wherein the measurement value is obtained by means of a sensor. | 2011-07-07 |
20110166427 | Point-of-Care Inventory Management System and Method - A system and method are disclosed for controlling an inventory of point-of-care diagnostic devices. The inventory includes a main inventory and at least one subinventory. Each device has an ambient temperature shelf life. Data associated with the devices is entered, including: the current quantity and predetermined minimum quantity of devices in the main inventory; and the current quantity and predetermined minimum quantity of devices in the subinventory. A first timestamp is associated with each device when the device is transferred from the main inventory to the ambient temperature subinventory. The first timestamp is compared to a second timestamp prior to use of the device to determine whether the device's ambient temperature shelf life is exceeded. The current quantity of devices in the subinventory is updated in response to an event that causes a change in the current quantity of devices in the subinventory. | 2011-07-07 |
20110166428 | NOVEL METHOD FOR MEASURING INSULIN RESISTANCE - Method of using at least one glucose derivative, halogenated in the 6 position, for the implementation of a process for the determination of insulin resistance in a mammal, in particular man, by measuring
| 2011-07-07 |
20110166429 | Integrated Colligation Evaluating Device for Human Body Enginery Indexes - An integrated colligation evaluating device for human body enginery indexes and the working method thereof. The device includes an equipment case ( | 2011-07-07 |
20110166430 | SYSTEM AND METHODS FOR ANALYZING SEIZURE ACTIVITY - The present invention provides systems and methods for ambulatory, long term monitoring of a physiological signal from a patient. At least a portion of the systems of the present invention may be implanted within the patient in a minimally invasive manner. In preferred embodiments, brain activity signals are sampled from the patient and are transmitted to a handheld patient communication device for further processing. | 2011-07-07 |
20110166431 | TAPE CASSETTE FOR A MEDICAL HANDHELD DEVICE - A tape cassette for a medical handheld device is disclosed as comprising a carrier tape, which carries test fields for assaying a sample of a human or animal bodily fluid and/or lancets as functional elements, a supply chamber, in which a supply section of the carrier tape comprising unused functional elements is positioned, a winding unit, in order to wind up the carrier tape and draw it through a tape exit opening of the chamber, so that the functional elements may be brought sequentially into a usage position. The carrier tape in the tape exit opening is oriented transversely to the supply section positioned in the supply chamber. | 2011-07-07 |
20110166432 | DIAGNOSTIC INTERLABIAL PAD - A diagnostic agent is delivered intravaginally or to the interlabial space by positioning an interlabial device, such as an absorbent pad, between the labia. The pad is retained between the labia to deliver an active agent, or allow a reaction with a diagnostic agent. Alternatively, the pad is applied after the diagnostic agent is administered, to help reduce discomfort to the subject, or loss of the diagnostic agent. The active agent may be carried by the pad itself, or in an intravaginal extension of the pad, or separately in a suppository or other dosage form. In particular examples, the pad has a smaller minor portion superimposed on a larger major portion, and the smaller minor portion is inserted as a leading edge between the labia of the subject to facilitate interlabial insertion. In another example, the pad is placed interlabially after insertion of an agent. | 2011-07-07 |
20110166433 | Systems, Methods, and Devices for Sampling Bodily Fluid - A fluid sampling system is disclosed comprising a fluid drawing device and a fluid sampling device. In one embodiment, the fluid sampling device has a base portion having a cannula, a handle, and a ridge extending around at least a portion of an outer surface. A top portion has a flange adapted to engage the ridge to couple the top portion to the base portion. In another embodiment, the fluid sampling device has a base portion having a cannula, a handle, a mounting portion, and a test strip coupled to the base portion at least partially within the mounting portion. In yet another embodiment, the fluid sampling device has a test strip housing for receiving an end of a test strip therein. Extending from an end of the test strip housing is a blunt cannula. | 2011-07-07 |
20110166434 | SYSTEM FOR SENSING ELECTROPHYSIOLOGICAL SIGNALS | 2011-07-07 |
20110166435 | SURGICAL ORIENTATION SYSTEM AND ASSOCIATED METHOD - The surgical orientation system is used to assist a surgeon to orient a prosthetic component relative to a patient's anatomy during surgery. An embodiment is particularly suited for assisting surgeons to locate an acetabular cup into a reamed acetabulum. The system includes: an implement ( | 2011-07-07 |
20110166436 | System and Method For Non-Contrast MR Angiography Using Steady-State Image Acquisition - A system and method is provided to quickly acquire and produce an MR angiogram without the use of a contrast agent. In quick succession, two MR image data sets of the vasculature of interest are acquired using a steady-state free precession (SSFP) pulse sequence. The SSFP pulse sequence gradient pulses differ for each image acquisition in that gradient pulses are balanced, or first moment nulled, for one acquisition, but not the other. Magnitude images are reconstructed from the two acquired image data sets and the magnitude images are subtracted to produce the MR angiogram. Contrast is provided by spin motion without the use of contrast agents and without the time consuming addition of motion encoding gradients or preparatory pulse sequences. | 2011-07-07 |
20110166437 | RECEIVING SURFACE COILS USED DURING THERMAL ABLATION PROCEDURE - A magnetic resonance imaging system to be used over a target area of a subject includes first and second RF coils for receiving an RF signal from the subject. The first RF coil is fixed to a position device and movable over the target area of subject. The second RF coil is larger than the first RF coil and has a larger field of view than the first RF coil. The system further includes an image processing device programmed to process RF signals coupled from the first RF coil and the second RF coil to form an MRI image. | 2011-07-07 |